
==== Front
BMC Musculoskelet Disord
BMC Musculoskelet Disord
BMC Musculoskeletal Disorders
1471-2474
BioMed Central London

7860
10.1186/s12891-024-07860-w
Research
The effects of simvastatin on the bone microstructure and mechanics of ovariectomized mice: a micro-CT and micro-finite element analysis study
Liang Yanbo 1
Yuan Xiaoqing 12
Dai Xiaoxue 3
Zhang Guohui 4
Li Changqin 1
Yang Hui 1
Zhang Tingting 1
Qin Jian sdqinjian@126.com

1
1 https://ror.org/05jb9pq57 grid.410587.f Department of Radiology, The Second Affiliated Hospital of Shandong First Medical University, No.366 Taishan Street, Tai’an City, Shandong Province 271000 China
2 https://ror.org/013xs5b60 grid.24696.3f 0000 0004 0369 153X Chinese institutes for medical research, Capital Medical University, Beijing, 100050 China
3 grid.452422.7 0000 0004 0604 7301 The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 271000 China
4 https://ror.org/05jb9pq57 grid.410587.f Shandong First Medical University, Jinan, Shandong 271000 China
18 9 2024
18 9 2024
2024
25 74814 2 2024
9 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Osteoporosis is a major health concern for postmenopausal women, and the effect of simvastatin (Sim) on bone metabolism is controversial. This study aimed to investigate the effect of simvastatin on the bone microstructure and bone mechanical properties in ovariectomized (OVX) mice.

Methods

24 female C57BL/6J mice (8-week-old) were randomly allocated into three groups including the OVX + Sim group, the OVX group and the control group. At 8 weeks after operation, the L4 vertebral bones were dissected completely for micro-Computed Tomography (micro-CT) scanning and micro-finite element analysis (µFEA). The differences between three groups were compared using ANOVA with a LSD correction, and the relationship between bone microstructure and mechanical properties was analyzed using linear regression.

Results

Bone volume fraction, trabecular number, connectivity density and trabecular tissue mineral density in the OVX + Sim group were significantly higher than those in the OVX group (P < 0.05). For the mechanical properties detected via µFEA, the OVX + Sim group had lower total deformation, equivalent elastic strain and equivalent stress compared to the OVX group (P < 0.05). In the three groups, the mechanical parameters were significantly correlated with bone volume fraction and trabecular bone mineral density.

Conclusions

The findings suggested that simvastatin had a potential role in the treatment of osteoporosis. The results of this study could guide future research on simvastatin and support the development of simvastatin-based treatments to improve bone health.

Keywords

Osteoporosis
Simvastatin
Micro-finite element
Bone microstructure
Academic Promotion Programme of Shandong First Medical UniversityNo.2019QL017 the Science and Technology Development Plan Project of Tai 'an2021NS251 issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Osteoporosis is a common health issue for the postmenopausal women, and its prevalence is increasing with the aging of the population [1]. Osteoporosis is characterized by decreased bone mineral density and microarchitectural deterioration of bone tissue that increases the risk of bone fragility and susceptibility to fracture [2]. Hormonal changes, especially the reduction of estrogen after menopause, play a key role in the development of osteoporosis. Estrogen deficiency in osteoporotic patients has been associated with decreased bone formation, increased bone resorption, and a reduction in bone mineral density [3]. In the past few decades, menopausal hormone therapy has been used not only to prevent the bone loss and the degeneration of bone microstructure, but also to reduce the incidence of osteoporotic fractures [4]. However, the discovery that it is related to the increased risk of cardiovascular events and breast cancer and other adverse health consequences has limited its use [5]. Although a study showed that bisphophonates lead to a decreased risk of cardiovascular events [6], there are also some literature suggesting that it has adverse effects, including gastrointestinal reactions [7] and an increased risk of cardiovascular events [8]. There is still controversy over the effects of bisphophonates on cardiovascular disease. Therefore, it is important to search a potential new treatment option for osteoporosis.

As an organic compound, Simvastatin (Sim) is classified as a statin drug. Sim is a specific inhibitor of 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) that is commonly used to reduce cholesterol levels and treat atherosclerosis and other cardiovascular diseases [9–12]. In addition, it has been shown to affect bone turnover by inhibiting osteoclast activity through decreasing osteoclast formation, differentiation, proliferation, and function, and stimulating bone formation through reducing osteoblast apoptosis [13]. Studies have suggested that simvastatin may have a potential role in the prevention and treatment of osteoporosis [14, 15]. The majority of related studies showed that simvastatin could increase bone mineral density, reduce bone resorption, and stimulate bone formation [16–18], while other studies detected a negative association between simvastatin and bone mineral density (BMD) and bone repair [19, 20]. The role of simvastatin in these animal model studies remains controversial.

In this study, we aimed to investigate the effect of simvastatin on the bone microstructure and bone mechanical properties in ovariectomized mice by micro-Computed Tomography (micro-CT) scanning combined with micro-finite element analysis (µFEA).

Methods

Animals and experimental treatment

A total of 24 female C57BL/6J mice (8-week-old) were randomly allocated into three groups with 8 mice per group. Eight mice received bilateral ovariectomy (OVX), which was the OVX+Sim group. After 4 weeks of postoperative adaption [21], then simvastatin (Sigma S6196-5MG) dissolved in physiological saline was administered to mice by oral gavage at a dose of 10 mg/kg per day [22] for 4 weeks. Eight mice (OVX group) underwent bilateral ovariectomy. The other eight mice (control group) were only performed back incision without ovariectomy. Then the mice in the OVX group and the control group received an equivalent amount of physiological saline as placebo for 4 weeks at 12 weeks of age. The living environment and rearing conditions (22–24℃ and 55–60% humidity in a room maintained on a 12/12-h light/dark cycle) of all mice were the same. The mice received ad libitum access to standard chow pellets and water throughout the experimental period.

At 16-week-old, mice in each group were euthanized by over anesthesia (Pentobarbital Sodium, 150 mg/kg) to extract the L4 vertebral bone completely. Then we stored them in 70% ethanol solution respectively. The study was approved by the Institutional Animal Care and Use Committee of our institution and was performed in accordance with the National Institutes of Health guidelines for the use of laboratory animals.

Micro-CT scanning

All trabecular bone of the L4 vertebral bones were examined with a micro-CT (NEMO micro-CT, model NMC-100) from PINGSENG Healthcare (Kunshan) Inc. All samples were placed in the sample holder vertically along the long axis. The scanning settings used were as follows: source voltage of 90 kV; current of 50 µA; scanning time of 10 min; voxel size of 0.015 × 0.015 × 0.015 mm; number of projections of 4000. After scanning, we used Avatar v1.6.5 (PINGSENG Healthcare lnc.) software to perform 3D reconstruction. The volume of interest (VOI) was seen in Fig. 1. We used segmentation algorithms such as thrshold segmentation, region growing, morphological operations and Boolean operations, and a threshold of 700 was used to extract the mineralized bone from soft tissue and marrow phase. The bone volume fraction (BV/TV)(%), trabecular thickness (Tb.Th)(mm), trabecular number (Tb.N)(1/mm), trabecular separation (Tb.Sp)(mm), structure model index (SMI), connectivity density (Conn.D)(1/mm3), trabecular tissue mineral density (Tb.TMD) (g/cm3) were evaluated based on the micro-CT scan results. All the measurements were performed by a junior physician under the supervision of a senior physician.

Fig. 1 The volume of interest is the volume of bone trabecular within the green line. A. coronal image B. sagittal image C. axial image

Micro-finite element analysis

Ansys17 (ANSYS Inc., USA) was used for micro-finite element analysis to simulate the axial compression tests for each trabecular bone in the longitudinal directions. Trabecular bone tissues were modelled as an isotropic linear elastic material with a Young’s modulus of 15 GPa and a Poisson’s ratio of 0.3 [23, 24]. For each bone segment model, uniaxial compression tests were performed for the µFEA analysis. This allowed us to determine total deformation, equivalent elastic strain and equivalent stress values, which represented the mechanical properties. Equivalent strain and equivalent stress respectively indicate the degree of deformation and tension inside the object. Equivalent elastic strain represents the overall deformation or elongation experienced by a material due to an applied load, considering both linear and nonlinear behavior. The equivalent elastic strain combines all the individual strain components (such as axial, shear, and volumetric strains) into a single value that represents the overall deformation. It is typically calculated using the Hooke’s law relationship between stress and strain for linear elastic materials. For nonlinear materials, more complex constitutive models are used. Equivalent stress is a scalar value that represents the intensity of stress at a point in a material, considering both normal and shear stresses. In complex stress states (such as multiaxial loading), different stress components (such as tensile, compressive, and shear stresses) act simultaneously. Equivalent stress simplifies this by combining all stress components into a single value. It is calculated as the square root of the sum of the squares of the deviatoric stresses.

Statistical analysis

All statistical analyzes were performed by SPSS software, version 27.0. The Shapiro-Wilk test was used to test the normality of the quantitative data. The results showed that all quantitative data approximately conformed to the normal distribution. Quantitative data are presented as the means ± standard deviation (SD). The Levene test was used for variance homogeneity analysis. Bone trabecular microstructural parameters among each group were compared by ANOVA with an LSD correction to account for intergroup differences between the three groups. Linear regression was used to analyze the relationship of trabecular bone microstructural parameters and micro-finite element parameters. A P value of less than 0.05 was considered to indicate statistical significance.

Results

Micro-CT scanning

There were significant intra-group differences between three groups in BV/TV, Tb.Th, Tb.N, Tb.Sp and Tb.TMD (P < 0.05) (Table 1; Fig. 2A and E). In contrast, SMI of vertebral bone did not show significant intra-group differences between three groups (P > 0.05) (Table 1). Specifically, the OVX + Sim group displayed a significant increase of BV/TV, Tb.N, Conn.D and Tb.TMD when compared to the OVX group (P < 0.05) (Table 1). Although there was no remarkable difference, the OVX + Sim group had more Tb.Th and less Tb.Sp when compared to the OVX group (P > 0.05) (Table 1). Interestingly, Tb.N and Conn.D in the OVX + Sim group were significantly higher than those in the control group (P < 0.05) (Table 1). And there was no remarkable difference of SMI in the OVX + Sim and control group (P > 0.05) (Table 1). Moreover, when compared to the control group, the OVX group showed a significant reduction in BV/TV, Tb.Th, Tb.N and Tb.TMD, while an increase in Tb.Sp (P < 0.05) (Table 1). Furthermore, three-dimensional reconstruction showed that the trabecular of the OVX+Sim group appeared to be denser than that of the control group and the OVX group (Fig. 3A and C).

Table 1 Comparison of microstructural parameters in three groups

Parameter	OVX + Sim group (n = 8)	Control group (n = 8)	OVX group (n = 8)	P-value	
Micro-CT	
BV/TV	0.347 ± 0.026a	0.386 ± 0.033b	0.307 ± 0.016	< 0.001*	
Tb.Th(mm)	0.086 ± 0.005	0.094 ± 0.0071b	0.081 ± 0.002	< 0.001*	
Tb.N(1/mm)	3.636 ± 0.204a	3.387 ± 0.294b	3.033 ± 0.091	< 0.001*	
Tb.Sp(mm)	0.189 ± 0.034	0.210 ± 0.031b	0.245 ± 0.013	0.002*	
SMI	0.158 ± 0.128	0.051 ± 0.166	0.113 ± 0.147	0.364	
Conn.D(1/mm3)	148.453 ± 28.990a	107.536 ± 14.098	110.730 ± 14.053	< 0.001*	
Tb.TMD(g/cm3)	1.311 ± 0.024a	1.355 ± 0.034b	1.284 ± 0.010	< 0.001*	
µFEA	
Total deformation (µm)	49.923 ± 8.994a	28.843 ± 6.073b	66.251 ± 12.729	< 0.001*	
Equivalent elastic strain (µm/µm)	0.029 ± 0.010a	0.020 ± 0.008b	0.049 ± 0.010	< 0.001	
Equivalent stress (Mpa)	132.899 ± 46.112a	101.868 ± 23.402b	244.696 ± 52.489	< 0.001	
Values represent mean ± SD

BV/TV: bone volume fraction, Tb.Th: trabecular thickness, Tb.N: trabecular number, Tb.Sp: trabecular separation, SMI: structure model index, Conn.D: connectivity density, Tb.TMD: trabecular tissue mineral density

*P < 0.05 between OVX + Sim and control group and remained significant

aP < 0.05 between OVX + Sim and OVX group and remained significant

bP < 0.05 between control and OVX group and remained significant

Fig. 2 Comparison of micro-CT parameters and mechanical properties of L4 vertebral bone for three groups of mice. A. BV/TV: bone volume fraction, B. Tb.Th: trabecular thickness, C. Tb.N: trabecular number, D. Tb.Sp: trabecular separation, E. Tb.TMD: trabecular tissue mineral density, F. total deformation, G. equivalent elastic strain, H. equivalent stress. * P < 0.05, ** P < 0.01, *** P < 0.001

Fig. 3 Three-dimensional reconstruction and sectional images of L4 vertebral bone of the mice closest to the average level in each group through micro-CT. A. control group B. OVX group C. OVX + Sim group

Micro-finite element analysis

For the mechanical properties detected via µFEA, the OVX + Sim group had lower total deformation, equivalent elastic strain and equivalent stress than did the OVX group (P < 0.05) (Table 1; Fig. 2F and H). The OVX + Sim group had higher total deformation than did the control group (P < 0.05) (Table 1; Fig. 2F and H). Moreover, the OVX group had higher total deformation, equivalent elastic strain and equivalent stress than did the control group (P < 0.05) (Table 1; Fig. 2F and H).

Correlation between trabecular bone parameters and bone strength

For all the samples (Table 2), total deformation, equivalent elastic strain and equivalent stress were negatively correlated with BV/TV (r=-0.837, -0.724 and − 0.876, P < 0.05, respectively), Tb.Th (r=-0.749, -0.450 and − 0.605, P < 0.05, respectively), Tb.TMD (r=-0.844, -0.617 and − 0.765, P < 0.05, respectively). Equivalent elastic strain and equivalent stress were negatively correlated with Tb.N (r=-0.635 and − 0.726, P < 0.05, respectively). Furthermore, equivalent elastic strain and equivalent stress were positively correlated with Tb.Sp (r = 0.607 and 0.678, P < 0.05, respectively).

Table 2 Correlation coefficient of linear regression between the microstructure and biomechanical properties in all three groups

Parameter	Total deformation (µm)	Equivalent elastic strain (µm/µm)	Equivalent stress (Mpa)	
r	P-value	r	P-value	r	P-value	
BV/TV	-0.837*	< 0.001	-0.724*	< 0.001	-0.876*	< 0.001	
Tb.Th(mm)	-0.749*	< 0.001	-0.450*	0.027	-0.605*	0.002	
Tb.N(1/mm)	-0.403	0.051	-0.635*	< 0.001	-0.726*	< 0.001	
Tb.Sp(mm)	0.374	0.071	0.607*	0.002	0.678*	< 0.001	
SMI	0.264	0.213	0.380	0.067	0.366	0.078	
Conn.D(1/mm3)	-0.094	0.662	-0.168	0.433	-0.328	0.118	
Tb.TMD(g/cm3)	-0.844*	< 0.001	-0.617*	0.001	-0.765*	< 0.001	
r, Pearson correlation coefficient. BV/TV: bone volume fraction, Tb.Th: trabecular thickness, Tb.N: trabecular number, Tb.Sp: trabecular separation, SMI: structure model index, Conn.D: connectivity density, Tb.TMD: trabecular tissue mineral density

The relationship varied when divided into different groups (Table 3). In the OVX + Sim group, total deformation and equivalent stress were negatively correlated with BV/TV (r=-0.864 and − 0.925, P < 0.05, respectively), Tb.N (r=-0.839 and − 0.901, P < 0.05, respectively). Total deformation, equivalent elastic strain and equivalent stress were also negatively correlated with Tb.TMD (r=-0.809, -0.714 and − 0.884, P < 0.05, respectively). In the control group and OVX group, equivalent stress was negatively correlated with BV/TV (r=-0.793 and − 0.802, P < 0.05, respectively).

Table 3 Correlation coefficient of linear regression between the microstructure and biomechanical properties in the treatment, control and module groups

Parameter	OVX + Sim group (n = 8)	Control group (n = 8)	OVX group (n = 8)	
Total deformation (µm)	Equivalent elastic strain (µm/µm)	Equivalent stress (Mpa)	Total deformation (µm)	Equivalent elastic strain (µm/µm)	Equivalent stress (Mpa)	Total deformation (µm)	Equivalent elastic strain (µm/µm)	Equivalent stress (Mpa)	
BV/TV	-0.864*	-0.667	-0.925*	-0.427	0.138	-0.793*	-0.421	-0.243	-0.802*	
Tb.Th(mm)	-0.231	-0.010	-0.324	-0.789*	0.685	-0.192	-0.173	0.153	0.025	
Tb.N(1/mm)	-0.839*	-0.696	-0.901*	0.406	-0.762*	-0.637	-0.158	0.557	-0.619	
Tb.Sp(mm)	0.683	0.725*	0.854*	-0.595	0.426	0.516	0.064	-0.149	0.170	
SMI	0.359	0.829*	0.392	-0.002	0.374	0.734*	0.242	0.394	0.702	
Conn.D(1/mm3)	-0.592	-0.600	-0.666	-0.528	0.374	-0.410	-0.515	0.113	-0.282	
Tb.TMD(g/cm3)	-0.809*	-0.714*	-0.884*	-0.776*	0.650	-0.375	-0.426	-0.355	-0.659	
r, Pearson correlation coefficient. BV/TV: bone volume fraction, Tb.Th: trabecular thickness, Tb.N: trabecular number, Tb.Sp: trabecular separation, SMI: structure model index, Conn.D: connectivity density, Tb.TMD: trabecular tissue mineral density

Figure 4 shows the results from the linear regression, assessing the associations of trabecular bone microstructural parameters with micro-finite element variables. Equivalent stress was negatively correlated with BV/TV (R2 = 0.767, P < 0.05). Total deformation was negatively correlated with BV/TV and Tb.TMD (R2 = 0.701, P < 0.05 and R2 = 0.711, P < 0.05, respectively).

Fig. 4 The scatter diagram and best-fit line between microstructure parameters and mechanical variables. *** P < 0.001

Discussion

Herein, we attempted to investigate the effect of simvastatin on the bone microstructure and mechanical properties in ovariectomized mice by micro-CT combined with micro-finite element analysis. Previous clinical studies have suggested that simvastatin may have a potential beneficial effect on bone metabolism, primarily by reducing bone resorption rather than stimulating bone formation [25–27]. It prevents estrogen deficiency-induced decrease in bone density [27]. However, data on the effects and mechanisms of simvastatin on bone structure have been limited to specific criteria, and accurate validation of its efficacy is needed [30–31]. In the present study, we aimed to determine the therapeutic potential of simvastatin in treating postmenopausal osteoporosis. This study selected clinically commonly used cholesterol-lowering drug simvastatin, using an ovariectomized mouse model to observe the effects of the drug on osteoporosis. We demonstrated that simvastatin can serve as a method for treating OVX-induced bone loss.

Estrogen plays an essential role in the process of bone remodeling [32–34]. Estrogen deficiency increases bone loss and osteoclast formation by increasing various cytokines and growth factors, and reduces the absorption and availability of intestinal calcium. The OVX animal model has been widely utilized in the study of postmenopausal osteoporosis caused by estrogen deficiency [35]. Our research found that ovariectomy could lead to a decrease in BV/TV, Tb.Th, Tb.N, Tb.TMD and an increase in Tb.Sp, total deformation, equivalent elastic strain and equivalent stress, which was in accordance with previous studies conducted on OVX mice [18, 36, 37]. Although there was no significant difference in Conn.D, we can also find that Conn.D decreased after ovariectomy. Previous studies reported that OVX mice not only lead to the decrease of bone mineral density, but also impaired the spatial structure of bone trabeculae and mechanical properties [38–40].

We observed that simvastatin treatment inhibited OVX-induced bone loss in mice. Wu et al. [41] studied the microstructure and mechanical properties of the axial bone in mice by comparing the changes in microstructure and mechanical properties of L4 vertebrae between ketogenic diet and OVX mice. And they found that OVX can damage the microstructure of the lumbar vertebrae in mice and lead to loss of cancellous bone. The most common osteoporotic fracture in the elderly population is vertebral compression fracture. Therefore, we selected the L4 vertebral body for observation. Cheon et al. [18] used two doses of statin, low dose (1 mg/kg) and high dose (10 mg/kg), respectively. In their experiment, the low-dose group did not effectively treat osteoporosis (many parameters were not significantly different from the control group). Meanwhile, we found in the study by Leutner et al. [20] that excessive doses (50 mg/kg) of simvastatin will promote the development of osteoporosis. In other words, excessive doses of simvastatin were harmful to bones. Therefore, a dose of 10 mg/kg of simvastatin was ultimately chosen for this study. Based on our analysis of 3D micro-CT images of the vertebra, simvastatin (10 mg/kg) significantly improved BV/TV, Tb.N, Conn.D and Tb.TMD. The results showed that simvastatin treatment not only increased bone density, but also improved the spatial structure of bone trabecular. Bone quality encompasses the microscopic structure of bone trabeculae, the macroscopic geometric structure of bone and the material properties of constituent bone tissues [42]. This study was consistent with those of previous studies [22, 37]. Recently, a cross-sectional analysis focused on the effects of statins on BMD in elderly males [43]. Consistent with our results, the oral treatment with therapeutic doses of statins was associated with a significant increase of BMD at L1-L4 in elderly men compared with the control group. A recent study [20] found that high doses of statin can damage bone quantity. As the mice were fed for a year in their experiments, the interference of age factors may be one reason for the discrepancy in the results [44].

While examining the mechanical properties of the trabeculae bone, we found that the total deformation, equivalent elastic strain and equivalent stress were reduced in the OVX + Sim group when compared with the OVX group, showing that simvastatin might improve mechanical properties and enhance bone strength caused by OVX. However, the total deformation in the OVX + Sim group was higher than that of the control group, indicating that simvastatin cannot completely reverse bone mechanical properties to normal levels. Through micro-CT scanning and biomechanical evaluations, Yang et al. [45] found that treatment with simvastatin was effective in enhancing bone strength and promoting bone defect repair. This difference may be due to the limited sample size in our study and we only studied the vertebral bones.

To discover the relationship between the microstructure and the mechanical properties of the vertebral trabeculae bone, we conducted a linear regression. We presented the correlations between microstructure and biomechanical properties both as all three groups separate and combined to explore group-specific effects while considering overall trends. Among these indicators, we found that BV/TV and Tb.TMD were negatively correlated with the mechanical properties. These findings indicated that the change of BV/TV in the vertebrae was crucial in the bone mechanical properties. Lamya Karim et al. found that the bone with high BV/TV had greater post-yield strain and stronger resistance to fractures than the bone with low BV/TV [46]. This showed that BV/TV is a prominent indicator reflecting bone mechanical properties and is positively associated with mechanical properties.

There are some limitations in this study. Firstly, the sample size of our study was small. Secondly, owing to only vertebrae bone being selected for analysis, it is difficult to determine whether this effect will vary according to the selected bone sites. Finally, this study only conducted two different analyses (micro-CT and µFEA). In future research, it is necessary to further explore the mechanism of action of simvastatin in the treatment of osteoporosis.

In conclusion, the present study using micro-CT combined with µFEA demonstrates that simvastatin treatment had a positive effect on the bone microstructure and mechanical properties of ovariectomized mice. Although the OVX-induced estrogen-deficient osteoporosis model may fail to comprehensively simulate clinical pathological conditions, the results of our study provided new insights into the potential clinical application of simvastatin for the treatment of osteoporosis.

Acknowledgements

The authors thank PINGSENG Healthcare (Kunshan) Inc., which provided technical assistance for this research.

Author contributions

Yb L: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing. Xq Y: Conceptualization, Data curation, Visualization, Writing – original draft, Writing – review & editing. Xx D: Conceptualization, Investigation. Gh Z: Conceptualization, Investigation. Cq L: Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing. H Y: Conceptualization, Writing - review & editing. Tt Z: Conceptualization, Project administration. J Q: Conceptualization, Supervision, Validation, Software, Writing - review & editing. All authors reviewed the manuscript.

Funding

This study was supported by Academic Promotion Programme of Shandong First Medical University (No.2019QL017) and the Science and Technology Development Plan Project of Tai ‘an(2021NS251).

Data availability

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

The study was approved by the Institutional Animal Care and Use Committee of Shandong First Medical University and carried out in accordance with the guidelines for the use of laboratory animals of the National Institutes of Health. This study was reported in accordance with ARRIVE guidelines.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Abbreviations

Sim Simvastatin

BMD Bone mineral density

µFEA Micro-finite element analysis

micro-CT Micro-Computed Tomography

OVX Ovariectomy

VOI Volume of interest

BV/TV Bone volume fraction

Tb.Th Trabecular thickness

Tb.N Trabecular number

Tb.Sp Trabecular separation

SMI Structure model index

Conn.D Connectivity density

Tb.TMD Trabecular tissue mineral density

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yanbo Liang and Xiaoqing Yuan are co-first authors.

Yanbo Liang and Xiaoqing Yuan contributed equally to this work.
==== Refs
References

1. Arceo-Mendoza RM Camacho PM Postmenopausal osteoporosis: latest guidelines Endocrinol Metab Clin North Am 2021 50 2 167 78 10.1016/j.ecl.2021.03.009 34023036
Arceo-Mendoza RM, Camacho PM. Postmenopausal osteoporosis: latest guidelines. Endocrinol Metab Clin North Am. 2021;50(2):167–78.34023036
2. Noh J-Y, Yang Y, Jung H. Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci. 2020; 21(20):7623.
3. Rozenberg S Bruyère O Bergmann P Cavalier E Gielen E Goemaere S How to manage osteoporosis before the age of 50 Maturitas 2020 138 14 25 10.1016/j.maturitas.2020.05.004 32631584
Rozenberg S, Bruyère O, Bergmann P, Cavalier E, Gielen E, Goemaere S, et al. How to manage osteoporosis before the age of 50. Maturitas. 2020;138:14–25.32631584
4. Gosset A Pouillès JM Trémollieres F Menopausal hormone therapy for the management of osteoporosis Best Pract Res Clin Endocrinol Metab 2021 35 6 101551 10.1016/j.beem.2021.101551 34119418
Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101551.34119418
5. Rozenberg S Al-Daghri N Aubertin-Leheudre M Brandi ML Cano A Collins P Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? Osteoporos Int 2020 31 12 2271 86 10.1007/s00198-020-05497-8 32642851
Rozenberg S, Al-Daghri N, Aubertin-Leheudre M, Brandi ML, Cano A, Collins P, et al. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? Osteoporos Int. 2020;31(12):2271–86.32642851
6. Kranenburg G, Bartstra J W, Weijmans M, de Jong P A, Mali W P, Verhaar H J, et al. Bisphosphonates for cardiovascular risk reduction: A systematic review and meta-analysis. Atherosclerosis. 2016;252: 106–15.
7. Tella SH Gallagher JC Prevention and treatment of postmenopausal osteoporosis J Steroid Biochem Mol Biol 2014 142 155 70 10.1016/j.jsbmb.2013.09.008 24176761
Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155–70.24176761
8. Pittman CB, Davis LA, Zeringue AL, Caplan L, Wehmeier KR, Scherrer JF et al. Myocardial infarction risk among patients with fractures receiving bisphosphonates. Mayo Clin Proc. 2014; 89(1): 43–51.
9. Xu XC Chen H Zhang X Zhai ZJ Liu XQ Qin A Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy J Transl Med 2014 12 284 10.1186/s12967-014-0284-0 25269614
Xu XC, Chen H, Zhang X, Zhai ZJ, Liu XQ, Qin A, et al. Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy. J Transl Med. 2014;12:284.25269614
10. Leutner M Matzhold C Bellach L Deischinger C Harreiter J Thurner S Diagnosis of osteoporosis in statin-treated patients is dose-dependent Ann Rheum Dis 2019 78 12 1706 11 10.1136/annrheumdis-2019-215714 31558481
Leutner M, Matzhold C, Bellach L, Deischinger C, Harreiter J, Thurner S, et al. Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Ann Rheum Dis. 2019;78(12):1706–11.31558481
11. Xiong M Xue Y Zhu W Deng A Tan Z Zhou G Comparative efficacy and safety of statins for osteoporosis: a study protocol for a systematic review and network meta-analysis BMJ Open 2022 12 5 e054158 10.1136/bmjopen-2021-054158 35580965
Xiong M, Xue Y, Zhu W, Deng A, Tan Z, Zhou G, et al. Comparative efficacy and safety of statins for osteoporosis: a study protocol for a systematic review and network meta-analysis. BMJ Open. 2022;12(5):e054158.35580965
12. Khayatan D, Razavi SM, Arab ZN, Khanahmadi M, Momtaz S, Butler AE et al. Regulatory effects of statins on SIRT1 and other Sirtuins in Cardiovascular diseases. Life (Basel). 2022;12(5):760.
13. Oryan A Alidadi S Moshiri A Maffulli N Bone regenerative medicine: classic options, novel strategies, and future directions J Orthop Surg Res 2014 9 1 18 10.1186/1749-799X-9-18 24628910
Oryan A, Alidadi S, Moshiri A, Maffulli N. Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res. 2014;9(1):18.24628910
14. Shahrezaee M Oryan A Bastami F Hosseinpour S Shahrezaee MH Kamali A Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats Endocrine 2018 60 1 138 50 10.1007/s12020-018-1531-6 29372484
Shahrezaee M, Oryan A, Bastami F, Hosseinpour S, Shahrezaee MH, Kamali A. Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats. Endocrine. 2018;60(1):138–50.29372484
15. Guo Y Huo J Wu D Hao H Ji X Zhao E Simvastatin inhibits the adipogenesis of bone marrow–derived mesenchymal stem cells through the downregulation of chemerin/CMKLR1 signaling Int J Mol Med 2020 46 2 751 61 10.3892/ijmm.2020.4606 32468037
Guo Y, Huo J, Wu D, Hao H, Ji X, Zhao E, et al. Simvastatin inhibits the adipogenesis of bone marrow–derived mesenchymal stem cells through the downregulation of chemerin/CMKLR1 signaling. Int J Mol Med. 2020;46(2):751–61.32468037
16. Chamani S Liberale L Mobasheri L Montecucco F Al-Rasadi K Jamialahmadi T The role of statins in the differentiation and function of bone cells Eur J Clin Invest 2021 51 7 e13534 10.1111/eci.13534 33656763
Chamani S, Liberale L, Mobasheri L, Montecucco F, Al-Rasadi K, Jamialahmadi T, et al. The role of statins in the differentiation and function of bone cells. Eur J Clin Invest. 2021;51(7):e13534.33656763
17. Feng C Xiao L Yu JC Li DY Tang TY Liao W Simvastatin promotes osteogenic differentiation of mesenchymal stem cells in rat model of osteoporosis through BMP-2/Smads signaling pathway Eur Rev Med Pharmacol Sci 2020 24 1 434 43 31957858
Feng C, Xiao L, Yu JC, Li DY, Tang TY, Liao W, et al. Simvastatin promotes osteogenic differentiation of mesenchymal stem cells in rat model of osteoporosis through BMP-2/Smads signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(1):434–43.31957858
18. Cheon Y-H Lee CH Kim S Park GD Kwak SC Cho HJ Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation Biomed Pharmacother 2021 139 111697 10.1016/j.biopha.2021.111697 34243614
Cheon Y-H, Lee CH, Kim S, Park GD, Kwak SC, Cho HJ, et al. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation. Biomed Pharmacother. 2021;139:111697.34243614
19. Kim SY, Yoo DM, Min C, Kim JH, Kwon MJ, Kim JH et al. Association between osteoporosis and previous statin use: a nested case-control study. Int J Environ Res Public Health. 2021;18(22):11902.
20. Leutner M Butylina M Matzhold C Klimek P Cuhaj C Bellach L Simvastatin therapy in higher dosages deteriorates bone quality: consistent evidence from population-wide patient data and interventional mouse studies Biomed Pharmacother 2023 158 114089 10.1016/j.biopha.2022.114089 36538862
Leutner M, Butylina M, Matzhold C, Klimek P, Cuhaj C, Bellach L, et al. Simvastatin therapy in higher dosages deteriorates bone quality: consistent evidence from population-wide patient data and interventional mouse studies. Biomed Pharmacother. 2023;158:114089.36538862
21. Cheon Y-H, Lee C H, Kim S, Park G D, Kwak S C, Cho H J, et al. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation. Biomed Pharmacother. 2021;139:111697.
22. Li H Gou Y Tian F Lian Q Hu Y Zhang L The combined anti-osteoporotic effects of simvastatin and exercise in ovariectomized mice fed a high-fat diet Exp Gerontol 2022 164 111794 10.1016/j.exger.2022.111794 35421557
Li H, Gou Y, Tian F, Lian Q, Hu Y, Zhang L. The combined anti-osteoporotic effects of simvastatin and exercise in ovariectomized mice fed a high-fat diet. Exp Gerontol. 2022;164:111794.35421557
23. Liu XS Walker MD McMahon DJ Udesky J Liu G Bilezikian JP Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women J Bone Min Res 2011 26 8 1783 92 10.1002/jbmr.378
Liu XS, Walker MD, McMahon DJ, Udesky J, Liu G, Bilezikian JP, et al. Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women. J Bone Min Res. 2011;26(8):1783–92.
24. Wang J Zhou B Liu XS Fields AJ Sanyal A Shi X Trabecular plates and rods determine elastic modulus and yield strength of human trabecular bone Bone 2015 72 71 80 10.1016/j.bone.2014.11.006 25460571
Wang J, Zhou B, Liu XS, Fields AJ, Sanyal A, Shi X, et al. Trabecular plates and rods determine elastic modulus and yield strength of human trabecular bone. Bone. 2015;72:71–80.25460571
25. Hong W Wei Z Qiu Z Li Z Fu C Ye Z Atorvastatin promotes bone formation in aged apoE(-/-) mice through the Sirt1-Runx2 axis J Orthop Surg Res 2020 15 1 303 10.1186/s13018-020-01841-0 32762716
Hong W, Wei Z, Qiu Z, Li Z, Fu C, Ye Z, et al. Atorvastatin promotes bone formation in aged apoE(-/-) mice through the Sirt1-Runx2 axis. J Orthop Surg Res. 2020;15(1):303.32762716
26. Monteiro LO Macedo AP Shimano RC Shimano AC Yanagihara GR Ramos J Effect of treatment with simvastatin on bone microarchitecture of the femoral head in an osteoporosis animal model Microsc Res Tech 2016 79 8 684 90 10.1002/jemt.22682 27186631
Monteiro LO, Macedo AP, Shimano RC, Shimano AC, Yanagihara GR, Ramos J, et al. Effect of treatment with simvastatin on bone microarchitecture of the femoral head in an osteoporosis animal model. Microsc Res Tech. 2016;79(8):684–90.27186631
27. Qadir F Alam SM Zehra T Mehmood A Siddiqi AQ Role of Pitavastatin in Prevention of Osteopenic Changes in Ovariectomized rats J Coll Physicians Surg Pak 2016 26 1 41 5 26787030
Qadir F, Alam SM, Zehra T, Mehmood A, Siddiqi AQ. Role of Pitavastatin in Prevention of Osteopenic Changes in Ovariectomized rats. J Coll Physicians Surg Pak. 2016;26(1):41–5.26787030
28. Lambers FM Kuhn G Schulte FA Koch K Müller R Longitudinal assessment of in vivo bone dynamics in a mouse tail model of postmenopausal osteoporosis Calcif Tissue Int 2012 90 2 108 19 10.1007/s00223-011-9553-6 22159822
Lambers FM, Kuhn G, Schulte FA, Koch K, Müller R. Longitudinal assessment of in vivo bone dynamics in a mouse tail model of postmenopausal osteoporosis. Calcif Tissue Int. 2012;90(2):108–19.22159822
29. Oliviero S Roberts M Owen R Reilly GC Bellantuono I Dall’Ara E Non-invasive prediction of the mouse tibia mechanical properties from microCT images: comparison between different finite element models Biomech Model Mechanobiol 2021 20 3 941 55 10.1007/s10237-021-01422-y 33523337
Oliviero S, Roberts M, Owen R, Reilly GC, Bellantuono I, Dall’Ara E. Non-invasive prediction of the mouse tibia mechanical properties from microCT images: comparison between different finite element models. Biomech Model Mechanobiol. 2021;20(3):941–55.33523337
30. Dai L Xu M Wu H Xue L Yuan D Wang Y The functional mechanism of simvastatin in experimental osteoporosis J Bone Min Metab 2016 34 1 23 32 10.1007/s00774-014-0638-y
Dai L, Xu M, Wu H, Xue L, Yuan D, Wang Y, et al. The functional mechanism of simvastatin in experimental osteoporosis. J Bone Min Metab. 2016;34(1):23–32.
31. Anagnostis P, Florentin M, Livadas S, Lambrinoudaki I, Goulis DG. Bone health in patients with Dyslipidemias: an underestimated aspect. Int J Mol Sci. 2022;23(3):1639.
32. Khosla S Oursler MJ Monroe DG Estrogen and the skeleton Trends Endocrinol Metab 2012 23 11 576 81 10.1016/j.tem.2012.03.008 22595550
Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012;23(11):576–81.22595550
33. Cheng CH, Chen LR, Chen KH. Osteoporosis due to hormone imbalance: an overview of the effects of Estrogen Deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci. 2022;23(3):1376.
34. McNamara LM. Osteocytes and estrogen deficiency. Curr Osteoporos Rep. 2021;19(6):592–603.
35. Yousefzadeh N Kashfi K Jeddi S Ghasemi A Ovariectomized rat model of osteoporosis: a practical guide Excli j 2020 19 89 107 32038119
Yousefzadeh N, Kashfi K, Jeddi S, Ghasemi A. Ovariectomized rat model of osteoporosis: a practical guide. Excli j. 2020;19:89–107.32038119
36. Guo X Yu X Yao Q Qin J Early effects of ovariectomy on bone microstructure, bone turnover markers and mechanical properties in rats BMC Musculoskelet Disord 2022 23 1 316 10.1186/s12891-022-05265-1 35366843
Guo X, Yu X, Yao Q, Qin J. Early effects of ovariectomy on bone microstructure, bone turnover markers and mechanical properties in rats. BMC Musculoskelet Disord. 2022;23(1):316.35366843
37. Ibrahim N Khamis MF Mod Yunoh MF Abdullah S Mohamed N Shuid AN Targeted delivery of lovastatin and tocotrienol to fracture site promotes fracture healing in osteoporosis model: micro-computed tomography and biomechanical evaluation PLoS ONE 2014 9 12 e115595 10.1371/journal.pone.0115595 25526611
Ibrahim N, Khamis MF, Mod Yunoh MF, Abdullah S, Mohamed N, Shuid AN. Targeted delivery of lovastatin and tocotrienol to fracture site promotes fracture healing in osteoporosis model: micro-computed tomography and biomechanical evaluation. PLoS ONE. 2014;9(12):e115595.25526611
38. Hsu PY Tsai MT Wang SP Chen YJ Wu J Hsu JT Cortical bone morphological and trabecular bone microarchitectural changes in the Mandible and femoral Neck of Ovariectomized rats PLoS ONE 2016 11 4 e0154367 10.1371/journal.pone.0154367 27127909
Hsu PY, Tsai MT, Wang SP, Chen YJ, Wu J, Hsu JT. Cortical bone morphological and trabecular bone microarchitectural changes in the Mandible and femoral Neck of Ovariectomized rats. PLoS ONE. 2016;11(4):e0154367.27127909
39. Li Z Liu P Yuan Y Liang X Lei J Zhu X Loss of longitudinal superiority marks the microarchitecture deterioration of osteoporotic cancellous bones Biomech Model Mechanobiol 2021 20 5 2013 30 10.1007/s10237-021-01491-z 34309757
Li Z, Liu P, Yuan Y, Liang X, Lei J, Zhu X, et al. Loss of longitudinal superiority marks the microarchitecture deterioration of osteoporotic cancellous bones. Biomech Model Mechanobiol. 2021;20(5):2013–30.34309757
40. Lei T Liang Z Li F Tang C Xie K Wang P Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice Bone 2018 108 10 9 10.1016/j.bone.2017.12.008 29229438
Lei T, Liang Z, Li F, Tang C, Xie K, Wang P, et al. Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice. Bone. 2018;108:10–9.29229438
41. Wu X Ding J Xu X Wang X Liu J Jiang J Ketogenic diet compromises vertebral microstructure and biomechanical characteristics in mice J Bone Min Metab 2019 37 6 957 66 10.1007/s00774-019-01002-2
Wu X, Ding J, Xu X, Wang X, Liu J, Jiang J, et al. Ketogenic diet compromises vertebral microstructure and biomechanical characteristics in mice. J Bone Min Metab. 2019;37(6):957–66.
42. Wang F Zheng L Theopold J Schleifenbaum S Heyde C-E Osterhoff G Methods for bone quality assessment in human bone tissue: a systematic review J Orthop Surg Res 2022 17 1 174 10.1186/s13018-022-03041-4 35313901
Wang F, Zheng L, Theopold J, Schleifenbaum S, Heyde C-E, Osterhoff G. Methods for bone quality assessment in human bone tissue: a systematic review. J Orthop Surg Res. 2022;17(1):174.35313901
43. Abbasloo S Aghaei Meybodi HR Fahimfar N Gharibzadeh S Sanjari M Khalaji K The associations of statin intake and the trabecular bone score and bone mineral density status in elderly Iranian individuals: a cross-sectional analysis of the Bushehr Elderly Health (BEH) program Arch Osteoporos 2021 16 1 144 10.1007/s11657-021-00991-w 34570258
Abbasloo S, Aghaei Meybodi HR, Fahimfar N, Gharibzadeh S, Sanjari M, Khalaji K, et al. The associations of statin intake and the trabecular bone score and bone mineral density status in elderly Iranian individuals: a cross-sectional analysis of the Bushehr Elderly Health (BEH) program. Arch Osteoporos. 2021;16(1):144.34570258
44. Yin H Shi ZG Yu YS Hu J Wang R Luan ZP Protection against osteoporosis by statins is linked to a reduction of oxidative stress and restoration of nitric oxide formation in aged and ovariectomized rats Eur J Pharmacol 2012 674 2–3 200 6 10.1016/j.ejphar.2011.11.024 22130356
Yin H, Shi ZG, Yu YS, Hu J, Wang R, Luan ZP, et al. Protection against osteoporosis by statins is linked to a reduction of oxidative stress and restoration of nitric oxide formation in aged and ovariectomized rats. Eur J Pharmacol. 2012;674(2–3):200–6.22130356
45. Li Y Zhang R Ren M Liu H Yang M Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats Heliyon 2022 8 9 e10480 10.1016/j.heliyon.2022.e10480 36105473
Li Y, Zhang R, Ren M, Liu H, Yang M. Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats. Heliyon. 2022;8(9):e10480.36105473
46. Karim L Vashishth D Role of trabecular microarchitecture in the formation, accumulation, and morphology of microdamage in human cancellous bone J Orthop Res 2011 29 11 1739 44 10.1002/jor.21448 21538510
Karim L, Vashishth D. Role of trabecular microarchitecture in the formation, accumulation, and morphology of microdamage in human cancellous bone. J Orthop Res. 2011;29(11):1739–44.21538510
